Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 30 days matching "Denmark"

ResearchBIORXIVMay 4

Preprint: Deep learning-based stratification of Schizophrenia Spectrum Disorder from real-world data reveals distinct profiles of common and rare variant genetic signal

Researchers studied over 22,000 people from Denmark to understand why schizophrenia affects people differently. They used artificial intelligence to find ten distinct groups within schizophrenia spectrum disorder based on clinical symptoms and genetic information. This discovery suggests that schizophrenia isn't one single disease but rather multiple related conditions with different genetic causes.

WHY IT MATTERSIf schizophrenia spectrum disorder can be divided into genetically distinct subtypes, future treatments could be personalized to match each person's specific genetic profile rather than using one-size-fits-all approaches.
Good to knowSchizophrenia Spectrum Disorder

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases